Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

A legfontosabb adatok

Ki végzi
Children's National Research Institute
Hol
Washington D.C. (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
10 fő, tervezett
Kezdés
2024. jan. 26.
Várható befejezés
2028. aug.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Focused Ultrasound Pallidotomy
A regiszteradat frissítve
2026. június 11.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for children and young adults with dystonia (uncontrolled twisting movements) caused by dyskinetic cerebral palsy. Their doctor has chosen GPi-DBS or pallidotomy, and they have chosen pallidotomy, here done with focused ultrasound.

Életkor
8 to 22 years
Nem
All sexes
A betegség stádiuma
Secondary dystonia due to cerebral palsy caused by lack of oxygen around birth (perinatal hypoxic injury). Brain areas globus pallidus internus and thalamus must look intact on MRI.
Korábbi kezelés
Medicines against dystonia have not helped enough. Dystonia medicines must have been stable for the last 30 days.
Biomarker vagy leletérték
Skull Density Ratio (SDR) of 0.40 or more. Head circumference of at least 49cm (19 in).

A részvétel fő kizáró okai

  • Primary (for example DYT1) or idiopathic dystonia
  • Severe spasticity (Modified Ashworth Scale >3), fixed hemi-dystonia or total loss of head control
  • Other severe brain disease, such as brain tumor or neurodegenerative disease
  • DBS leads in place, or a condition likely to need MRI in the future
  • Pregnancy, breastfeeding, or blood thinners that cannot be stopped around surgery

A regiszter feltételei, szó szerint

Mind a 35 feltétel megnézéseKevesebb

Ki vehet részt

  • The treating physician has chosen GPi-DBS or pallidotomy for the treatment of the secondary dystonia caused by cerebral palsy in this patient
  • Patient and/or legal representative, if the patient is underaged or not capable to give consent himself, have chosen pallidotomy as treatment
  • The consent to participate in the trial of the underaged patient, if he is capable to understand the study requirements, is required
  • Age at enrolment 8-22 years
  • Diagnosis of secondary dystonia due to cerebral palsy caused by perinatal hypoxic injury
  • Anti-dystonic pharmacotherapy insufficient
  • Stable anti-dystonic medication over the last 30 days
  • Globus pallidus internus (pars posterior) and thalamus (motor part) intact on MRI (not older than 2 years - if possible)
  • No fixed severe skeletal deformations with loss of function, which need immediate orthopaedic surgical intervention
  • Sufficient compliance of the patient or the legal representative if the patient is underaged or not capable to give consent himself to take part in the study
  • Informed consent to take part in the study from patient and/or legal representative if the patient is underaged or not capable to give consent himself
  • Patient and/or legal representative if the patient is underaged or not capable to give consent himself, understands the study requirements and the treatment procedures and provides written informed consent before any study-specific tests or procedures are performed

Ki nem vehet részt

  • Severe axial hypotonia with total loss of head control (e.g. absence of control at "upper thoracic level" in the SATCo score) (medication effect excluded)
  • Fixed severe skeletal contractions with loss of function which require immediate orthopaedic surgical intervention
  • Patients with other severe concurrent neurological disease (e. g. brain tumor, neurodegenerative diseases, trauma etc.)
  • Any findings in neuropsychological screening assessments that would contraindicate DBS surgery
  • Any current drug and / or alcohol abuse
  • Any other active implanted device (e.g. Cochlear implant, pacemaker), whether turned on or off, would be allowed provided that they do not interfere with functioning of the device
  • Currently on any anticoagulant medications that cannot be discontinued during perioperative period
  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days; any other trial participation should be approved by the Principal Investigator
  • Condition likely to require use of MRI in the future
  • Any intracranial abnormality or medical condition that would contraindicate DBS surgery
  • Any history of frequent grand-mal seizures without response to anticonvulsive treatment
  • A history of neurostimulation intolerance in any area of the body
  • Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival <24 months
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data
  • Patients with known primary (e.g. DYT1) or idiopathic dystonia
  • Fixed hemi-dystonia
  • Severe spasticity in knee- and elbow-flexors and -extensors (Modified Ashworth Scale >3)
  • The presence of DBS leads due the risks of these ferromagnetic devices in the MRI environment
  • A female that is breastfeeding or of childbearing potential with a positive urine pregnancy test or - if a person is sexually active - not using sufficient contraception with a Pearl Index of less than 1% including all forms of hormonal contraception ("antibaby-pill", hormonal plaster, NuvaRing®, Implanon®, hormonal depot injections, contraceptive coil), the tubal ligature (female sterilization). Alternatively, the female of child bearing potential is sexually abstinent
  • Subjects who have contraindications to anesthesia, in the judgment of the attending anesthesiologist
  • Subjects who are unwilling or unable to undergo general anesthesia
  • Minimum head circumference < 49cm
  • Skull Density Ratio (SDR) <0.40

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 8 és 22 év között vagy?

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Children's National HospitalWashington D.C., Egyesült ÁllamokContact: Chima Oluigbo, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy

A vizsgálat csoportja

  • Focused Ultrasound PallidotomyA vizsgált kezelés

    Pediatric and young adult patients between ages of 8 and 22 years with pharmaco-resistant secondary dystonia due to dyskinetic cerebral palsy who have Focused Ultrasound Pallidotomy

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Safety and Impact on Quality of Life of Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT06036199: ki vehet részt
A regiszteradat frissítve
2026. június 11.